Markets boom for generic cancer drugs
Cancer generics is slated to be the next growth driver for generic drug manufacturers in India and elsewhere, with an increasing number of blockbuster patents expiring, combined with geographic
Cancer generics is slated to be the next growth driver for generic drug manufacturers in India and elsewhere, with an increasing number of blockbuster patents expiring, combined with geographic